Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Klaus Friedrich Gratz"'
Autor:
Steven W. Warmann, Mona Hunger, Klaus Friedrich Gratz, Birgit Teichmann, Peter Ruck, Jörg Fuchs, Heike Heitmann
Publikováno v:
Pediatric Hematology and Oncology. 22:373-386
Multidrug resistance (MDR) contributes to limited treatment results in human hepatoblastoma (HB). The MDR1 gene and its product P-glycoprotein (P-gP) has been identified as important factor in this development. In other tumors, P-gP modulation leads
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6be371b56297ce774dadc20ab53a65c
https://doi.org/10.1080/08880010590964192
https://doi.org/10.1080/08880010590964192
Autor:
Steven Warmann, Ludwig Wilkens, Klaus Friedrich Gratz, Jörg Fuchs, Dietrich von Schweinitz, Hermann Mildenberger
Publikováno v:
Medical and Pediatric Oncology. 37:449-454
Background Human hepatoblastoma is an infrequent liver tumor in children. Although many hepatoblastomas can be treated adequately with well-defined treatment regimens, problems still persist with advanced and non-resectable tumors; in these cases, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc4431a34f978a54ef81ad2a381f025
https://doi.org/10.1002/mpo.1228
https://doi.org/10.1002/mpo.1228
Autor:
Dietrich von Schweinitz, Peter Gielow, Klaus Friedrich Gratz, Jörg Fuchs, Richard P. Baum, Götz Habild
Publikováno v:
Journal of Pediatric Surgery. 34:1378-1384
Background/Purpose: Hepatoblastoma (HB) is the most common primary malignant liver tumor affecting infants and young children. The α-fetoprotein level is elevated in 95% of all children with hepatoblastoma. Therefore, it is of interest to assess tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c2d11ea94837145cf3adc9fe12e176
https://doi.org/10.1016/s0022-3468(99)90015-5
https://doi.org/10.1016/s0022-3468(99)90015-5
Autor:
Dieter, Hörsch, Samer, Ezziddin, Alexander, Haug, Klaus Friedrich, Gratz, Simone, Dunkelmann, Bernd Joachim, Krause, Carl, Schümichen, Frank M, Bengel, Wolfram H, Knapp, Peter, Bartenstein, Hans-Jürgen, Biersack, Ursula, Plöckinger, Sabine, Schwartz-Fuchs, R P, Baum
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 194
Peptide receptor radionuclide therapy is an effective treatment option for patients with well-differentiated somatostatin receptor-expressing neuroendocrine tumors. However, published data result mainly from retrospective monocentric studies. We init
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::092a9cd24c5e1f154fe7a8ee27ae730a
https://pubmed.ncbi.nlm.nih.gov/22918775
https://pubmed.ncbi.nlm.nih.gov/22918775